EVERYONE ... JUST DO IT!!! LAST DAY!!!! Posted By:

New Post Public Reply Private Reply Replies (1) Message Board
CyberC riskreward007 #50628
513

EVERYONE ... JUST DO IT!!! LAST DAY!!!!

Posted By: riskreward007

Re: Contacting Director Iancu and two senators about 101 Mayhem (Last day: Today, March 8) :

Templates:
https://investorshangout.com/post/view?id=5371947
https://investorshangout.com/post/view?id=5372010

Here’s the emails I sent this morning based on copy/paste templates (from CyberC and baldeagle1) a big thanks to you both)!!!

Either write your own message or just copy, paste and email the templates below.
Or you can go to twitter and leave messages there.

Director Iancu:
email: eligibility2019@uspto.gov
re: 101 Mayhem

Dear Director Iancu:

I would like to thank you for your initiative to resolve the 101 mayhem. Your subject matter eligibility guidance will help with most of the 101 problems if interpreted and implemented properly by the examiners and PTAB judges. Therefore, the highest risk to your subject matter eligibility guidance is the interpretation and implementation by the examiners and PTAB judges. The following are suggestions on how to further improve the guidance and how to ensure its correct interpretation and implementation.

1. In the article https://www.ipwatchdog.com/2019/01/28/directo...id=105649/, an “examiner wrongly thought that the new guidance created a new ‘practical application’ burden that needed to be met by an applicant to overcome an existing Section 101 rejection. This is contrary to the guidance actually identifying an alternative path to establishing that a claim is patentable under Section 101 ‘if the judicial exception is integrated into a practical application of the judicial exception.’” This shows how easily confused some examiners can be. Hence, it is critically important to include in the guidance or its training material the purpose of the guidance. For example: “In addition to predictability, the purpose of the guidance is to provide alternative paths to patent eligibility, thereby substantially reducing the number of 101 rejections”.

This high-level clarification right in the general purpose of the guidance will set a clear tone for the guidance and avoid confusion such as described in the referenced article.

2. The guidance states that a claim is patent eligible if it does not recite an abstract idea (i.e. mathematical concept, etc.) “on its own or per se”. For computer implemented inventions, it is a real possibility, and even likelihood, that some examiners will ignore the “on its own or per se” requirement and will interpret this as a claim being patent ineligible if it recites an element that uses a mathematical concept. All computer implemented inventions include elements that use mathematical concepts at some level. Therefore, some examiners will wrongly continue issuing 101 rejections for computer implemented inventions, whereas, this is clearly not the intent of the guidance.

It is critically important that the guidance or its training material provides at least one example of a claim for a computer implemented invention that recites only a mathematical concept that is not patent eligible (i.e. a method comprising adding A and B to result in C). It is further critically important that the guidance or its training material provides at least one example of a claim for a computer implemented invention that recites elements that use mathematical concepts, but do not recite mathematical concepts “on their own or per se”, that is patent eligible (i.e. a method comprising: receiving or generating a, b, and c using some process or analysis; generating data structure A including a, b, and c; accessing data structure B in a memory of a computer; evaluating data structure A and data structure B to determine at least partial match; causing the computer or a device controlled by the computer to perform some operation based on the determination).

3. The guidance mentions that:
“a judicial exception has not been integrated into a practical application: … [if it] merely includes instructions to implement an abstract idea on a computer, or merely uses a computer as a tool to perform an abstract idea”.

This language is clearly directed to fundamental business practices, organizing human activities, and other well-established human practices that use a computer merely as a tool (see the Supreme Court opinion in Alice v. CLS Bank International, 134 S. Ct. 2347 (2014). This language is clearly not directed to computer implemented inventions (i.e. artificial intelligence, robotics, autonomous vehicles and devices, image processing, databases, computer/video games, computer simulations, content processing, and many more) that arise out of or are inherently implemented on a computer. It is unimaginably irrational to attempt to make computer implemented inventions that arise out of or are inherently implemented on a computer patent ineligible simply because they are implemented on a computer.

Therefore, it is critically important to include in the new guidance or its training material an explanation that the language stating that “a judicial exception has not been integrated into a practical application: … [if it] merely includes instructions to implement an abstract idea on a computer, or merely uses a computer as a tool to perform an abstract idea” applies only to fundamental business practices, organizing human activities, and other well-established human practices that use a computer merely as a tool and that computer implemented inventions (i.e. artificial intelligence, robotics, autonomous vehicles and devices, image processing, databases, computer/video games, computer simulations, content processing, and many more) that arise out of or are inherently implemented on a computer are patent eligible as the patent law explicitly states.

4. It has been a long trend that many examiners routinely label all non-hardware elements of a computer implemented invention as abstract ideas with no, marginal, or incomplete analysis and label all hardware elements as “additional elements”. The examiners then merely state that the “additional elements” are well-known and do not add anything to the abstract ideas. This initial misclassification of abstract ideas and “additional elements” then prevents examiners from ever analyzing whether non-hardware elements are well understood, routine, or conventional as required in step 2B of the Alice/Mayo framework, since the analysis of whether an element is well understood, routine, or conventional applies only to the “additional elements”. This is an irresponsible practice and examiners who practice this should be identified and educated to correct their practice. It is critically important to clearly state in the guidance or its training material that only non-hardware elements that recite an abstract idea “on its own or per se” are abstract ideas and all other non-hardware elements are “additional elements”.

5. It is often the case in computer implemented inventions that a data structure, combination of data structures, element including a data structure, process that operates on a data structure, process that uses a data structure, or other element related to a data structure provides crucial novelty and enables a novel system. It has been a long trend that many examiners routinely label data structures or anything related to data structures as abstract ideas with no, marginal, or incomplete analysis. Since many computer implemented inventions use data structures, these inventions were unjustly doomed to patent ineligibility right from the start.

In the guidance’s groupings of abstract ideas, the only one that has any relation to data structures is “Mathematical concepts—mathematical relationships, mathematical formulas or equations, mathematical calculations”. Since a data structure IS an arrangement—often very complex —of data stored in memory, a data structure IS NOT a mathematical relationship, mathematical formula or equation, or mathematical calculation. Hence, a data structure is not an abstract idea. Further, many data structures – especially complex ones such as trees, graphs, neural networks, variously linked nodes, variously linked data structures, etc.—are embodiments of a practical application described under prong 2 of the guidance as patent eligible. Therefore, it is critically important to clearly state in the guidance or its training material that data structures are not abstract ideas and that inventions reciting data structures are patent eligible.

6. It has been a recent trend to issue blanket 101 rejections with no, marginal, or incomplete analysis in art units dealing with artificial intelligence inventions. This is an irresponsible practice and examiners who practice this should be identified and educated to correct their practice. It is beyond belief that the United States would cripple itself by limiting innovation in a crucial field such as AI, especially in view of the heated global race for dominance in this field. It is critically important to clearly state in the guidance or its training material that artificial intelligence inventions are patent eligible.

Sincerely,



re: 101 Mayhem

Senator (Tillis or Coons),

We appreciate your effort in pushing forthcoming legislation regarding patent litigation currently, and in the future, impacted by the Alice101 rulings. There apparently is much confusion in its relationship to and involvement in patent validity, and patent infringement cases. Director Iancu/USPTO has requested support as per the following excerpt from the link to his press release, also shown below.

“Director Iancu needs us to support him with positive public comments as justification for his Section 101 guidance and to suggest improvements to his guidance for its final/future version(s) and its implementation.”

https://www.ipwatchdog.com/2019/03/05/a-plea-...id=106976/

I, along with many others seek your support as well, on legislation in which I believe you are currently involved! We are hoping that the legislation will provide a clear path to resolve the Alice 101 issues, once and for all.

We greatly appreciate your time and consideration regarding these issues, and for taking the time to read Director Iancu's Plea for Help!

Respectfully,

To leave an email for either of these senators click on the links below. Then fill out the online form (with name, address, phone number etc. ) and include your message.

Email contacts:

Senator Christopher Coons

https://www.coons.senate.gov/contact/email-chris

Senator Thom Tillis:

https://www.tillis.senate.gov/public/index.cfm/email-me


Note: This is Easy-Peasy. It took me less than five minutes to send email messages to Director Iancu and both senators , -using the message templates already provided.

Reminder: you need to do this by today, March 8!! !


Thank you to everyone who writes, calls and tweets this important message .

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Health Hit by FTC Claims and Class Action

Updated Category News Views 1

Hims Faces Harsh Lessons With FTC Lawsuit There's trouble brewing in the world of telehealth, and Hims & Hers Health (NYSE: HIMS) is right at the eye of the storm. They've gone from a darling of digital health to a pariah faster than you can say 'data breach.' On July 29, 2026, they took a hit so hard you’d think the company stepped into the ring with a heavyweight...

Continue Reading
U.S. Court Ruling Opens Market for Cocrystal's CrysQnol™

Updated Category News Views 1

Legal Drama Clears Market Path Well, folks, here’s a win from the trenches for Cocrystal Tech that can shake up the nutraceutical market. Kaneka's grip on the patent for their ubiquinol concoctions just got busted by the U.S. District Court. They ruled that Kaneka's claims lacked utility and enablement, essentially saying they were pitching an untested hypothesis as an...

Continue Reading
Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 1

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Insurance 101: Know Your Limits and Deductibles

Updated Category News Views 4

It might not exactly be cocktail party fodder, but boy, skipping on understanding your homeowners insurance is a shortcut straight to financial hell. You’re living in St. Albans, WV, in a home that’s probably your biggest investment. Let’s talk about this before you find yourself in a mess you should've seen coming. Why Coverage Limits Matter a Whole Lot Listen up,...

Continue Reading
vivo and UNESCO Unite Youth for Nature Stories

Updated Category News Views 4

Young Creators Explore Nature Through a New Lens Pontremoli, Italy just became the backdrop for an extraordinary gathering of young visionaries. From August 31 to September 5, UNESCO’s Man and the Biosphere (MAB) Programme and vivo wrapped their 2026 Capture the Future initiative in the lush landscapes of the Appennino Tosco Emiliano Biosphere Reserve. It’s one thing...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 4

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Nurminen Logistics Doubles Sweden–Italy Rail Capacity

Updated Category News Views 4

Nurminen Logistics Betting Big on Rail Expansion Feeling the pulse of the logistics world is much like trying to catch lightning in a bottle, but Nurminen Logistics seems to have found its rhythm. They're ramping up their services between Sweden and Italy, leveraging rail to push the envelope. Come October, they're doubling down from one to two weekly departures, giving...

Continue Reading
ACG Moves to Acquire Ke?kek for $7.85M Gold Venture

Updated Category News Views 3

Here's the scoop: ACG Metals Limited is stepping up the game, attempting to snag the Ke?kek gold project in a deal worth up to $7.85 million. This move, they say, is all about bolstering the future of their gold production—and squeezing every ounce out of that Gediktepe facility in Türkiye. It's like squeezing juice from a lemon that's still got a bit of life left....

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 3

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Consumer365 Highlights Happy Head's Personalized Hair Solutions

Updated Category News Views 1

Tailored Hair Loss Solutions by Happy Head Imagine trying to fit a square peg in a round hole. That's what one-size-fits-all approaches often feel like in the world of hair loss treatments. Happy Head, recognized by Consumer365, takes that notion and turns it on its head, offering personalized minoxidil formulations for women. The key word here is personalized. More Than...

Continue Reading

Top 5 Most Recently Viewed Articles

Cloudera Launches Innovative Accelerators to Enhance AI Progress

Updated Category News Views 101

Cloudera’s Accelerators Boosting AI Innovation Cloudera has introduced a thrilling new lineup of Accelerators for Machine Learning Projects (AMPs), designed to revolutionize how businesses leverage AI. These innovations act as catalysts, enabling companies to implement AI technologies more efficiently and quickly, significantly shortening the time it takes to deploy...

Continue Reading
TMC Metals Company Investors Take Notice: Class Action Filed

Updated Category News Views 124

Understanding the Class Action Lawsuit for TMC Investors The Law Offices of Frank R. Cruz has initiated a class action lawsuit aimed at protecting investors who purchased shares of TMC the metals company Inc. during a specified investment period. TMC investors are being informed about the opportunity to participate in this lawsuit, which could provide redress for...

Continue Reading
Craig Jacobson's Strategic Sale: Insights into Expedia Group's Stock

Updated Category News Views 145

Craig Jacobson's recent stock sale at Expedia Group In a significant move on a recent trading day, Craig Jacobson, Director at Expedia Group, made headlines by selling 3,000 shares of the company. This insider transaction, reported through a Form 4 filing, revealed that Jacobson netted approximately $623,328 from this sale. Current Trends of Expedia Group Stock As of the...

Continue Reading
TRG International Update: Share Transfer of Former Chairman

Updated Category News Views 179

TRG International Announces Major Share Transfer Action Enforcement Proceedings For Unpaid Arbitration Award also Underway in the United States and Pakistan. On a significant note, TRG International has recently revealed that the Bermuda Supreme Court ordered the transfer of all shares held by its former Chairman, Zia Chishti. This decision aims to ensure that outstanding...

Continue Reading
Avalon GloboCare Teams Up with Saga Health for KetoAir Launch

Updated Category News Views 106

Avalon GloboCare Partners with Saga Health Avalon GloboCare Corp. (NASDAQ: ALBT), a leader in precision diagnostic consumer products, has officially teamed up with Saga Health Corporation. This collaboration centers around a wholesale distribution agreement for the KetoAir™ breathalyzer, specifically designed for first responders. Introducing the Innovative KetoAir™...

Continue Reading